aTYR PHARMA INC Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
aTYR PHARMA INC quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • aTYR PHARMA INC Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $882K, a 30.7% decline year-over-year.
  • aTYR PHARMA INC Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $4.24M, a 13% increase year-over-year.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2023 was $4.52M, a 326% increase from 2022.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2022 was $1.06M, a 346% increase from 2021.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2021 was $238K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.52M +$3.46M +326% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.06M +$823K +346% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $238K +$557K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$319K +$466K +59.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$785K +$910K +53.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$1.7M -$633K -59.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-24
2017 -$1.06M -$1.1M -3050% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
2016 $36K +$393K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 -$357K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.